Advertisement

Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN

      Abstract

      Radiotherapy plays an important role in the management of childhood cancer, with the primary aim of achieving the highest likelihood of cure with the lowest risk of radiation-induced morbidity. Proton therapy (PT) provides an undisputable advantage by reducing the radiation ‘bath’ dose delivered to non-target structures/volume while optimally covering the tumor with tumoricidal dose. This treatment modality comes, however, with an additional costs compared to conventional radiotherapy that could put substantial financial pressure to the health care systems with societal implications.
      In this review we assess the data available to the oncology community of PT delivered to children with cancer, discuss on the urgency to develop high-quality data. Additionally, we look at the advantage of combining systemic agents with protons and look at the cost-effectiveness data published so far.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Steliarova-Foucher E.
        • Colombet M.
        • Ries L.A.G.
        • Moreno F.
        • Dolya A.
        • Bray F.
        • et al.
        International incidence of childhood cancer, 2001–10: a population-based registry study.
        Lancet Oncol. 2017; 18: 719-731
        • Habrand J.L.
        • Stefan D.
        • Bolle S.
        D. L, Helfre S, Alapetite C. The impact of particle therapy in pediatric tumors with emphasis on clinical toxicity. Ped Blood.
        Cancer. 2017; 64: 365-433
        • MacDonald S.M.
        • Safai S.
        • Trofimov A.
        • Wolfgang J.
        • Fullerton B.
        • Yeap B.Y.
        • et al.
        Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.
        Int J Radiat Oncol Biol Phys. 2008; 71: 979-986
        • Merchant T.E.
        • Li C.
        • Xiong X.
        • Kun L.E.
        • Boop F.A.
        • Sanford R.A.
        Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study.
        Lancet Oncol. 2009; 10: 258-266
        • Reynolds M.R.
        • Haydon D.H.
        • Caird J.
        • Leonard J.R.
        Radiation-Induced Moyamoya Syndrome after Proton Beam Therapy in the Pediatric Patient: A Case Series.
        Pediatr Neurosurg. 2016; 51: 297-301
        • Merchant T.E.
        • Hua C.H.
        • Shukla H.
        • Ying X.
        • Nill S.
        • Oelfke U.
        Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.
        Pediatr Blood Cancer. 2008; 51: 110-117
        • Mahajan A.
        Proton Craniospinal Radiation Therapy: Rationale and Clinical Evidence.
        Int J Particle Therapy. 2014; 1: 399-407
        • St Clair W.H.
        • Adams J.A.
        • Bues M.
        • Fullerton B.C.
        • La Shell S.
        • Kooy H.M.
        • et al.
        Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.
        Int J Radiat Oncol Biol Phys. 2004; 58: 727-734
        • Yock T.I.
        • Yeap B.Y.
        • Ebb D.H.
        • Weyman E.
        • Eaton B.R.
        • Sherry N.A.
        • et al.
        Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
        Lancet Oncol. 2016; 17: 287-298
        • Paulino A.C.
        • Mahajan A.
        • Ye R.
        • Grosshans D.R.
        • Fatih Okcu M.
        • Su J.
        • et al.
        Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
        Radiother Oncol. 2018;
        • Michalski J.M.
        • Janss A.
        • Vezina G.
        • Gajjar A.
        • Pollack I.
        • Merchant T.E.
        • et al.
        Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group.
        Int J Radiat Oncol Biol Phys. 2016; 96: 937-938
        • Taylor M.D.
        • Northcott P.A.
        • Korshunov A.
        • Remke M.
        • Cho Y.J.
        • Clifford S.C.
        • et al.
        Molecular subgroups of medulloblastoma: the current consensus.
        Acta Neuropathol. 2012; 123: 465-472
        • Yoon M.
        • Shin D.H.
        • Kim J.
        • Kim J.W.
        • Kim D.W.
        • Park S.Y.
        • et al.
        Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy.
        Int J Radiat Oncol Biol Phys. 2011; 81: 637-646
        • Giantsoudi D.
        • Seco J.
        • Eaton B.R.
        • Simeone F.J.
        • Kooy H.
        • Yock T.I.
        • et al.
        Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
        Int J Radiat Oncol Biol Phys. 2017; 98: 37-46
        • Merchant T.E.
        Current management of childhood ependymoma.
        Oncology (Williston Park). 2002; 16 (629–42, 44; discussion 45–6, 48)
        • Greenlee R.T.
        • Murray T.
        • Bolden S.
        • Wingo P.A.
        Cancer statistics, 2000.
        CA Cancer J Clin. 2000; 50: 7-33
        • Dhall G.
        • Grodman H.
        • Ji L.
        • Sands S.
        • Gardner S.
        • Dunkel I.J.
        • et al.
        Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols.
        Pediatr Blood Cancer. 2008; 50: 1169-1175
        • Smyth M.D.
        • Horn B.N.
        • Russo C.
        • Berger M.S.
        Intracranial ependymomas of childhood: current management strategies.
        Pediatr Neurosurg. 2000; 33: 138-150
        • Merchant T.E.
        • Fouladi M.
        Ependymoma: new therapeutic approaches including radiation and chemotherapy.
        J Neurooncol. 2005; 75: 287-299
        • van Veelen-Vincent M.L.
        • Pierre-Kahn A.
        • Kalifa C.
        • Sainte-Rose C.
        • Zerah M.
        • Thorne J.
        • et al.
        Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy.
        J Neurosurg. 2002; 97: 827-835
        • Merchant T.E.
        Three-dimensional conformal radiation therapy for ependymoma.
        Childs Nerv Syst. 2009; 25: 1261-1268
        • Massimino M.
        • Miceli R.
        • Giangaspero F.
        • Boschetti L.
        • Modena P.
        • Antonelli M.
        • et al.
        Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.
        Neuro Oncol. 2016; 18: 1451-1460
      1. Foreman NK, Love S, Gill SS, Coakham HB. Second-look surgery for incompletely resected fourth ventricle ependymomas: technical case report. Neurosurgery. 1997;40:856-60; discussion 60.

      2. ClinicalTrials.gov. Observation or radiation therapy and/or chemotherapy and second surgery in treating children who have undergone surgery for ependymoma. Sponsored by the National Cancer Institute. Available at: <https://clinicaltrials.gov/ct2/show/NCT00027846>; 2016 [accessed 11.17.16].

        • Armstrong G.T.
        • Liu Q.
        • Yasui Y.
        • Huang S.
        • Ness K.K.
        • Leisenring W.
        • et al.
        Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood cancer survivor study.
        J Natl Cancer Inst. 2009; 101: 946-958
        • Kahalley L.S.
        • Ris M.D.
        • Grosshans D.R.
        • Okcu M.F.
        • Paulino A.C.
        • Chintagumpala M.
        • et al.
        Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors.
        J Clin Oncol. 2016; 34: 1043-1049
        • Merchant T.E.
        • Conklin H.M.
        • Wu S.
        • Lustig R.H.
        • Xiong X.
        Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.
        J Clin Oncol. 2009; 27: 3691-3697
        • Greenberger B.A.
        • Pulsifer M.B.
        • Ebb D.H.
        • MacDonald S.M.
        • Jones R.M.
        • Butler W.E.
        • et al.
        Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas.
        Int J Radiat Oncol Biol Phys. 2014; 89: 1060-1068
        • Rickert C.H.
        • Paulus W.
        Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification.
        Childs Nerv Syst. 2001; 17: 503-511
        • Packer R.J.
        • Biegel J.A.
        • Blaney S.
        • Finlay J.
        • Geyer J.R.
        • Heideman R.
        • et al.
        Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
        J Pediatr Hematol Oncol. 2002; 24: 337-342
        • Tekautz T.M.
        • Fuller C.E.
        • Blaney S.
        • Fouladi M.
        • Broniscer A.
        • Merchant T.E.
        • et al.
        Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
        J Clin Oncol. 2005; 23: 1491-1499
        • Chi S.N.
        • Zimmerman M.A.
        • Yao X.
        • Cohen K.J.
        • Burger P.
        • Biegel J.A.
        • et al.
        Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.
        J Clin Oncol. 2009; 27: 385-389
        • Burger P.C.
        • Yu I.T.
        • Tihan T.
        • Friedman H.S.
        • Strother D.R.
        • Kepner J.L.
        • et al.
        Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a pediatric oncology group study.
        Am J Surg Pathol. 1998; 22: 1083-1092
        • Weiss E.
        • Behring B.
        • Behnke J.
        • Christen H.J.
        • Pekrun A.
        • Hess C.F.
        Treatment of primary malignant rhabdoid tumor of the brain: report of three cases and review of the literature.
        Int J Radiat Oncol Biol Phys. 1998; 41: 1013-1019
        • Squire S.E.
        • Chan M.D.
        • Marcus K.J.
        Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy.
        J Neurooncol. 2007; 81: 97-111
        • De Amorim Bernstein K.
        • Sethi R.
        • Trofimov A.
        • Zeng C.
        • Fullerton B.
        • Yeap B.Y.
        • et al.
        Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors.
        Int J Radiat Oncol Biol Phys. 2013; 86: 114-120
        • Elsayad K.
        • Kriz J.
        • Samhouri L.
        • Haverkamp U.
        • Straeter R.
        • Stummer W.
        • et al.
        Long-term survival following additive radiotherapy in patients with atypical teratoid rhabdoid tumors.
        Strahlenther Onkol. 2016; 192: 569-581
        • Weber D.C.
        • Ares C.
        • Malyapa R.
        • Albertini F.
        • Calaminus G.
        • Kliebsch U.
        • et al.
        Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy.
        J Neurooncol. 2015; 121: 389-397
        • Fitzek M.M.
        • Linggood R.M.
        • Adams J.
        • Munzenrider J.E.
        Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at harvard cyclotron laboratory and massachusetts general hospital.
        Int J Radiat Oncol Biol Phys. 2006; 64: 1348-1354
        • Laffond C.
        • Dellatolas G.
        • Alapetite C.
        • Puget S.
        • Grill J.
        • Habrand J.L.
        • et al.
        Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy.
        Brain Inj. 2012; 26: 270-281
        • Bishop A.J.
        • Greenfield B.
        • Mahajan A.
        • Paulino A.C.
        • Okcu M.F.
        • Allen P.K.
        • et al.
        Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
        Int J Radiat Oncol Biol Phys. 2014; 90: 354-361
        • Luu Q.T.
        • Loredo L.N.
        • Archambeau J.O.
        • Yonemoto L.T.
        • Slater J.M.
        • Slater J.D.
        Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report.
        Cancer J. 2006; 12: 155-159
        • Ostrom Q.T.
        • Gittleman H.
        • Liao P.
        • Vecchione-Koval T.
        • Wolinsky Y.
        • Kruchko C.
        • et al.
        CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014.
        Neuro Oncol. 2017; 19: v1-v88
        • Jellinger K.
        Primary intracranial germ cell tumours.
        Acta Neuropathol. 1973; 25: 291-306
        • Maity A.
        • Shu H.K.
        • Janss A.
        • Belasco J.B.
        • Rorke L.
        • Phillips P.C.
        • et al.
        Craniospinal radiation in the treatment of biopsy-proven intracranial germinomas: twenty-five years’ experience in a single center.
        Int J Radiat Oncol Biol Phys. 2004; 58: 1165-1170
        • Huh S.J.
        • Shin K.H.
        • Kim I.H.
        • Ahn Y.C.
        • Ha S.W.
        • Park C.I.
        Radiotherapy of intracranial germinomas.
        Radiother Oncol. 1996; 38: 19-23
        • Ogawa K.
        • Shikama N.
        • Toita T.
        • Nakamura K.
        • Uno T.
        • Onishi H.
        • et al.
        Long-term results of radiotherapy for intracranial germinoma: a multi-institutional retrospective review of 126 patients.
        Int J Radiat Oncol Biol Phys. 2004; 58: 705-713
        • MacDonald S.M.
        • Trofimov A.
        • Safai S.
        • Adams J.
        • Fullerton B.
        • Ebb D.
        • et al.
        Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.
        Int J Radiat Oncol Biol Phys. 2011; 79: 121-129
        • Robertson P.L.
        • DaRosso R.C.
        • Allen J.C.
        Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy.
        J Neuro Oncol. 1997; 32: 71-80
        • Kim J.W.
        • Kim W.C.
        • Cho J.H.
        • Kim D.S.
        • Shim K.W.
        • Lyu C.J.
        • et al.
        A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
        Int J Radiat Oncol Biol Phys. 2012; 84: 625-631
        • Richards A.T.
        • Stricke L.
        • Spitz L.
        Sacrococcygeal chordomas in children.
        J Pediatr Surg. 1973; 8: 911-914
        • Cable D.G.
        • Moir C.
        Pediatric sacrococcygeal chordomas: a rare tumor to be differentiated from sacrococcygeal teratoma.
        J Pediatr Surg. 1997; 32: 759-761
        • Al-Adra D.
        • Bennett A.
        • Gill R.
        • Lees G.
        Pediatric metastatic sacrococcygeal chordoma treated with surgery.
        Eur J Pediatr Surg. 2011; 21: 196-198
        • Hoch B.L.
        • Nielsen G.P.
        • Liebsch N.J.
        • Rosenberg A.E.
        Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases.
        Am J Surg Pathol. 2006; 30: 811-818
        • Borba L.A.
        • Al-Mefty O.
        • Mrak R.E.
        • Suen J.
        Cranial chordomas in children and adolescents.
        J Neurosurg. 1996; 84: 584-591
        • Probst E.N.
        • Zanella F.E.
        • Vortmeyer A.O.
        Congenital clivus chordoma.
        AJNR Am J Neuroradiol. 1993; 14: 537-539
        • Benk V.
        • Liebsch N.J.
        • Munzenrider J.E.
        • Efird J.
        • McManus P.
        • Suit H.
        Base of skull and cervical spine chordomas in children treated by high-dose irradiation.
        Int J Radiat Oncol Biol Phys. 1995; 31: 577-581
        • Matsumoto J.
        • Towbin R.B.
        • Ball Jr., W.S.
        Cranial chordomas in infancy and childhood. a report of two cases and review of the literature.
        Pediatr Radiol. 1989; 20: 28-32
        • Ridenour 3rd, R.V.
        • Ahrens W.A.
        • Folpe A.L.
        • Miller D.V.
        Clinical and histopathologic features of chordomas in children and young adults.
        Pediatr Dev Pathol. 2010; 13: 9-17
        • Coffin C.M.
        • Swanson P.E.
        • Wick M.R.
        • Dehner L.P.
        Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases.
        Arch Pathol Lab Med. 1993; 117: 927-933
        • Kaneko Y.
        • Sato Y.
        • Iwaki T.
        • Shin R.W.
        • Tateishi J.
        • Fukui M.
        Chordoma in early childhood: a clinicopathological study.
        Neurosurgery. 1991; 29: 442-446
        • Hug E.B.
        • Sweeney R.A.
        • Nurre P.M.
        • Holloway K.C.
        • Slater J.D.
        • Munzenrider J.E.
        Proton radiotherapy in management of pediatric base of skull tumors.
        Int J Radiat Oncol Biol Phys. 2002; 52: 1017-1024
        • Gadwal S.R.
        • Fanburg-Smith J.C.
        • Gannon F.H.
        • Thompson L.D.
        Primary chondrosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 14 cases with a review of the literature.
        Cancer. 2000; 88: 2181-2188
        • Combs S.E.
        • Kessel K.A.
        • Herfarth K.
        • Jensen A.
        • Oertel S.
        • Blattmann C.
        • et al.
        Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data.
        Radiat Oncol. 2012; 7: 170
        • Rombi B.
        • Ares C.
        • Hug E.B.
        • Schneider R.
        • Goitein G.
        • Staab A.
        • et al.
        Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at paul scherrer institute.
        Int J Radiat Oncol Biol Phys. 2013; 86: 578-584
        • Choi G.H.
        • Yang M.S.
        • Yoon D.H.
        • Shin H.C.
        • Kim K.N.
        • Yi S.
        • et al.
        Pediatric cervical chordoma: report of two cases and a review of the current literature.
        Childs Nerv Syst. 2010; 26: 835-840
      3. Kaatsch P, Spix C. German Childhood Cancer Registry – Annual Report 2015 (1980–2014). Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz. Available from: <http://wwwkinderkrebsregisterde/dkkr-gb/latest-publications/annual-reports/annual-report-2015html?L=1>; 2015 [accessed 20.11.17].

        • Ward E.
        • DeSantis C.
        • Robbins A.
        • Kohler B.
        • Jemal A.
        Childhood and adolescent cancer statistics, 2014.
        CA Cancer J Clin. 2014; 64: 83-103
      4. Hiniker SM, Donaldson SS. Recent advances in understanding and managing rhabdomyosarcoma. F1000prime reports. 2015;7:59.

        • Yang L.
        • Takimoto T.
        • Fujimoto J.
        Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma.
        BMC Cancer. 2014; 14: 654
        • Merks J.H.
        • De Salvo G.L.
        • Bergeron C.
        • Bisogno G.
        • De Paoli A.
        • Ferrari A.
        • et al.
        Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.
        Ann Oncol. 2014; 25: 231-236
        • Timmermann B.
        • Schuck A.
        • Niggli F.
        • Weiss M.
        • Lomax A.J.
        • Pedroni E.
        • et al.
        Spot-scanning proton therapy for malignant soft tissue tumors in childhood: first experiences at the Paul Scherrer Institute.
        Int J Radiat Oncol Biol Phys. 2007; 67: 497-504
        • Frisch S.
        • Timmermann B.
        The evolving role of proton beam therapy for sarcomas.
        Clin oncol (R Coll Radiol ((Great Britain)). 2017; 29: 500-506
      5. [74] Timmermann B, Schuck A, Niggli F, Weiss M, Lomax A, Goitein G. [“Spot-scanning” proton therapy for rhabdomyosarcomas of early childhood. First experiences at PSI]. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]. 2006;182:653–9.

        • Kozak K.R.
        • Adams J.
        • Krejcarek S.J.
        • Tarbell N.J.
        • Yock T.I.
        A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
        Int J Radiat Oncol Biol Phys. 2009; 74: 179-186
        • Ladra M.M.
        • Edgington S.K.
        • Mahajan A.
        • Grosshans D.
        • Szymonifka J.
        • Khan F.
        • et al.
        A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.
        Radiother Oncol: Journal Eur Soc Ther Radiol Oncol. 2014; 113: 77-83
        • Yock T.
        • Schneider R.
        • Friedmann A.
        • Adams J.
        • Fullerton B.
        • Tarbell N.
        Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
        Int J Radiat Oncol Biol Phys. 2005; 63: 1161-1168
        • Weber D.C.
        • Trofimov A.V.
        • Delaney T.F.
        • Bortfeld T.
        A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
        Int J Radiat Oncoly Biol Phys. 2004; 58: 1596-1606
        • Cotter S.E.
        • Herrup D.A.
        • Friedmann A.
        • Macdonald S.M.
        • Pieretti R.V.
        • Robinson G.
        • et al.
        Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
        Int J Radiat Oncol Biol Phys. 2011; 81: 1367-1373
        • Ladra M.M.
        • Szymonifka J.D.
        • Mahajan A.
        • Friedmann A.M.
        • Yong Yeap B.
        • Goebel C.P.
        • et al.
        Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma.
        J Clin Oncol. 2014; 32: 3762-3770
        • Leiser D.
        • Calaminus G.
        • Malyapa R.
        • Bojaxhiu B.
        • Albertini F.
        • Kliebsch U.
        • et al.
        Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy.
        Radiother Oncol: J Eur Soc Ther Radiol Oncol. 2016;
        • Weber D.C.
        • Ares C.
        • Albertini F.
        • Frei-Welte M.
        • Niggli F.K.
        • Schneider R.
        • et al.
        Pencil beam scanning proton therapy for pediatric parameningeal rhabdomyosarcomas: clinical outcome of patients treated at the Paul Scherrer Institute.
        Pediatr Blood Cancer. 2016; 63: 1731-1736
        • Childs S.K.
        • Kozak K.R.
        • Friedmann A.M.
        • Yeap B.Y.
        • Adams J.
        • MacDonald S.M.
        • et al.
        Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.
        Int J Radiat Oncol Biol Phys. 2012; 82: 635-642
        • Curtis A.E.
        • Okcu M.F.
        • Chintagumpala M.
        • Teh B.S.
        • Paulino A.C.
        Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
        Int J Radiat Oncol Biol Phys. 2009; 73: 173-177
        • Wolden S.L.
        • Wexler L.H.
        • Kraus D.H.
        • Laquaglia M.P.
        • Lis E.
        • Meyers P.A.
        Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
        Int J Radiat Oncol Biol Phys. 2005; 61: 1432-1438
        • Combs S.E.
        • Behnisch W.
        • Kulozik A.E.
        • Huber P.E.
        • Debus J.
        • Schulz-Ertner D.
        Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma.
        BMC Cancer. 2007; 7: 177
        • Weber D.C.
        • Murray F.R.
        • Correia D.
        • Bolsi A.
        • Frei-Welte M.
        • Pica A.
        • et al.
        Pencil beam scanned protons for the treatment of patients with Ewing sarcoma.
        Pediatr Blood Cancer. 2017; 64
        • Stiller C.A.
        • Bielack S.S.
        • Jundt G.
        • Steliarova-Foucher E.
        Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project.
        Eur J Cancer. 2006; 42: 2124-2135
        • Sundaresan N.
        • Rosen G.
        • Boriani S.
        Primary malignant tumors of the spine.
        Orthop Clin North Am. 2009; 40: 21-36
        • Rodriguez-Galindo C.
        • Liu T.
        • Krasin M.J.
        • Wu J.
        • Billups C.A.
        • Daw N.C.
        • et al.
        Analysis of prognostic factors in ewing sarcoma family of tumors: review of St.Jude Children's Research Hospital studies.
        Cancer. 2007; 110: 375-384
        • Granowetter L.
        • Womer R.
        • Devidas M.
        • Krailo M.
        • Wang C.
        • Bernstein M.
        • et al.
        Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
        J Clin Oncol. 2009; 27: 2536-2541
        • Rombi B.
        • DeLaney T.F.
        • MacDonald S.M.
        • Huang M.S.
        • Ebb D.H.
        • Liebsch N.J.
        • et al.
        Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes.
        Int J Radiat Oncol Biol Phys. 2012; 82: 1142-1148
        • Ahmed S.K.
        • Randall R.L.
        • DuBois S.G.
        • Harmsen W.S.
        • Krailo M.
        • Marcus K.J.
        • et al.
        Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.
        Int J Radiat Oncol Biol Phys. 2017; 99: 1286-1294
        • Hundsdoerfer P.
        • Albrecht M.
        • Ruhl U.
        • Fengler R.
        • Kulozik A.E.
        • Henze G.
        Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
        Eur J Cancer. 2009; 45: 2447-2451
        • Kager L.
        • Zoubek A.
        • Dominkus M.
        • Lang S.
        • Bodmer N.
        • Jundt G.
        • et al.
        Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group.
        Cancer. 2010; 116: 5316-5324
        • Brady J.S.
        • Chung S.Y.
        • Marchiano E.
        • Eloy J.A.
        • Baredes S.
        • Park R.C.W.
        Pediatric head and neck bone sarcomas: An analysis of 204 cases.
        Int J Pediatr Otorhinolaryngol. 2017; 100: 71-76
        • DeLaney T.F.
        • Park L.
        • Goldberg S.I.
        • Hug E.B.
        • Liebsch N.J.
        • Munzenrider J.E.
        • et al.
        Radiotherapy for local control of osteosarcoma.
        Int J Radiat Oncol Biol Phys. 2005; 61: 492-498
        • Ciernik I.F.
        • Niemierko A.
        • Harmon D.C.
        • Kobayashi W.
        • Chen Y.L.
        • Yock T.I.
        • et al.
        Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.
        Cancer. 2011; 117: 4522-4530
        • Leroy R.
        • Benahmed N.
        • Hulstaert F.
        • Van Damme N.
        • De Ruysscher D.
        Proton Therapy in Children: A Systematic Review of Clinical Effectiveness in 15 Pediatric Cancers.
        Int J Radiat Oncol Biol Phys. 2016; 95: 267-278
        • Chung C.S.
        • Yock T.I.
        • Nelson K.
        • Xu Y.
        • Keating N.L.
        • Tarbell N.J.
        Incidence of second malignancies among patients treated with proton versus photon radiation.
        Int J Radiat Oncol Biol Phys. 2013; 87: 46-52
        • Mouw K.W.
        • Sethi R.V.
        • Yeap B.Y.
        • MacDonald S.M.
        • Chen Y.L.
        • Tarbell N.J.
        • et al.
        Proton radiation therapy for the treatment of retinoblastoma.
        Int J Radiat Oncol Biol Phys. 2014; 90: 863-869
        • Agarwal A.
        • Thaker N.G.
        • Bouchra T.
        • Allen P.K.
        • Grosshans D.R.
        • Herzog C.E.
        • et al.
        The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience.
        Int J Particle Therapy. 2016; 2: 190-498
        • Inskip P.D.
        • Sigurdson A.J.
        • Veiga L.
        • Bhatti P.
        • Ronckers C.
        • Rajaraman P.
        • et al.
        Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.
        Int J Radiat Oncol Biol Phys. 2016; 94: 800-807
        • van Nimwegen F.A.
        • Schaapveld M.
        • Cutter D.J.
        • Janus C.P.
        • Krol A.D.
        • Hauptmann M.
        • et al.
        Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.
        J Clin Oncol. 2016; 34: 235-243
        • Tseng Y.D.
        • Cutter D.J.
        • Plastaras J.P.
        • Parikh R.R.
        • Cahlon O.
        • Chuong M.D.
        • et al.
        Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
        Int J Radiat Oncol Biol Phys. 2017; 99: 825-842
        • Maraldo M.V.
        • Brodin N.P.
        • Aznar M.C.
        • Vogelius I.R.
        • Munck af Rosenschold P.
        • Petersen PM P.M.
        • et al.
        Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.
        Ann Oncol. 2013; 24: 2113-2118
        • Hoppe B.S.
        • Tsai H.
        • Larson G.
        • Laramore G.E.
        • Vargas C.
        • Tseng Y.D.
        • et al.
        Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry.
        Acta Oncol. 2016; 55: 1378-1380
        • Hoppe B.S.
        • Hill-Kayser C.E.
        • Tseng Y.D.
        • Flampouri S.
        • Elmongy H.M.
        • Cahlon O.
        • et al.
        Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma.
        Ann Oncol. 2017; 28: 2179-2184
        • Wray J.
        • Flampouri S.
        • Slayton W.
        • Joyce M.
        • Sandler E.
        • Morris C.G.
        • et al.
        Proton Therapy for Pediatric Hodgkin Lymphoma.
        Pediatr Blood Cancer. 2016; 63: 1522-1526
        • Nanda R.
        • Flampouri S.
        • Mendenhall N.P.
        • Indelicato D.J.
        • Jones L.M.
        • Seeram V.K.
        • et al.
        Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma.
        Int J Radiat Oncol Biol Phys. 2017; 99: 494-497
        • Hoppe B.S.
        • Flampouri S.
        • Zaiden R.
        • Slayton W.
        • Sandler E.
        • Ozdemir S.
        • et al.
        Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
        Int J Radiat Oncol Biol Phys. 2014; 89: 1053-1059
        • Ojerholm E.
        • Hill-Kayser C.E.
        Reply to comment on: Insurance coverage decisions for pediatric proton therapy.
        Pediatr Blood Cancer. 2017;
        • Evans A.E.
        • Baum E.
        • Chard R.
        Do infants with stage IV-S neuroblastoma need treatment?.
        Arch Dis Child. 1981; 56: 271-274
        • Evans A.E.
        • D'Angio G.J.
        • Propert K.
        • Anderson J.
        • Hann H.W.
        Prognostic factor in neuroblastoma.
        Cancer. 1987; 59: 1853-1859
        • Carlsen N.L.
        • Christensen I.J.
        • Schroeder H.
        • Bro P.V.
        • Erichsen G.
        • Hamborg-Pedersen B.
        • et al.
        Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases.
        Cancer. 1980; 1986: 2726-2735
        • Brodeur G.M.
        • Seeger R.C.
        • Schwab M.
        • Varmus H.E.
        • Bishop J.M.
        Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
        Science. 1984; 224: 1121-1124
        • Caron H.
        • van Sluis P.
        • de Kraker J.
        • Bokkerink J.
        • Egeler M.
        • Laureys G.
        • et al.
        Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
        N Engl J Med. 1996; 334: 225-230
        • Haase G.M.
        • O'Leary M.C.
        • Ramsay N.K.
        • Romansky S.G.
        • Stram D.O.
        • Seeger R.C.
        • et al.
        Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma.
        J Pediatr Surg. 1991; 26 (discussion 23-4): 1119-1123
        • Matthay K.K.
        • Atkinson J.B.
        • Stram D.O.
        • Selch M.
        • Reynolds C.P.
        • Seeger R.C.
        Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study.
        J Clin Oncol. 1993; 11: 2226-2233
        • Halperin E.C.
        Hepatic metastasis from neuroblastoma.
        South Med J. 1987; 80: 1370-1373
        • Hug E.B.
        • Nevinny-Stickel M.
        • Fuss M.
        • Miller D.W.
        • Schaefer R.A.
        • Slater J.D.
        Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique.
        Med Pediatr Oncol. 2001; 37: 36-41
        • Hillbrand M.
        • Georg D.
        • Gadner H.
        • Potter R.
        • Dieckmann K.
        Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy.
        Radiother Oncol. 2008; 89: 141-149
        • Rombi B.
        • Vennarini S.
        • Vinante L.
        • Ravanelli D.
        • Amichetti M.
        Proton radiotherapy for pediatric tumors: review of first clinical results.
        Ital J Pediatr. 2014; 40: 74
        • Fuji H.
        • Schneider U.
        • Ishida Y.
        • Konno M.
        • Yamashita H.
        • Kase Y.
        • et al.
        Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.
        Radiat Oncol. 2013; 8: 255
        • Hattangadi J.A.
        • Rombi B.
        • Yock T.I.
        • Broussard G.
        • Friedmann A.M.
        • Huang M.
        • et al.
        Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.
        Int J Radiat Oncol Biol Phys. 2012; 83: 1015-1022
        • Hill-Kayser C.
        • Tochner Z.
        • Both S.
        • Lustig R.
        • Reilly A.
        • Balamuth N.
        • et al.
        Proton versus photon radiation therapy for patients with high-risk neuroblastoma: the need for a customized approach.
        Pediatr Blood Cancer. 2013; 60: 1606-1611
        • Oshiro Y.
        • Mizumoto M.
        • Okumura T.
        • Sugahara S.
        • Fukushima T.
        • Ishikawa H.
        • et al.
        Clinical results of proton beam therapy for advanced neuroblastoma.
        Radiat Oncol. 2013; 8: 142
        • Grundy P.E.
        • Breslow N.E.
        • Li S.
        • Perlman E.
        • Beckwith J.B.
        • Ritchey M.L.
        • et al.
        Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
        J Clin Oncol. 2005; 23: 7312-7321
        • Chagtai T.
        • Zill C.
        • Dainese L.
        • Wegert J.
        • Savola S.
        • Popov S.
        • et al.
        Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.
        J Clin Oncol. 2016; 34: 3195-3203
        • Vogel J.
        • Lin H.
        • Both S.
        • Tochner Z.
        • Balis F.
        • Hill-Kayser C.
        Pencil beam scanning proton therapy for treatment of the retroperitoneum after nephrectomy for Wilms tumor: A dosimetric comparison study.
        Pediatr Blood Cancer. 2017; 64: 39-45
        • Kalapurakal J.A.
        • Li S.M.
        • Breslow N.E.
        • Beckwith J.B.
        • Ritchey M.L.
        • Shamberger R.C.
        • et al.
        Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.
        Int J Radiat Oncol Biol Phys. 2010; 76: 201-206
        • Sullivan R.
        • Peppercorn J.
        • Sikora K.
        • Zalcberg J.
        • Meropol N.J.
        • Amir E.
        • et al.
        Delivering affordable cancer care in high-income countries.
        Lancet Oncol. 2011; 12: 933-980
        • Trogdon J.G.
        • Tangka F.K.
        • Ekwueme D.U.
        • Guy Jr., G.P.
        • Nwaise I.
        • Orenstein D.
        State-level projections of cancer-related medical care costs: 2010 to 2020.
        Am J Manag Care. 2012; 18: 525-532
        • Truffer C.J.
        • Keehan S.
        • Smith S.
        • Cylus J.
        • Sisko A.
        • Poisal J.A.
        • et al.
        Health spending projections through 2019: the recession's impact continues.
        Health Aff (Millwood). 2010; 29: 522-529
        • Goozner M.
        Strategies to reduce cancer-care costs.
        J Natl Cancer Inst. 2013; 105: 247-248
        • Goitein M.
        • Jermann M.
        The relative costs of proton and X-ray radiation therapy.
        Clin Oncol (R Coll Radiol). 2003; 15: S37-S50
        • Emanuel E.J.
        • Fuchs V.R.
        • Garber A.M.
        Essential elements of a technology and outcomes assessment initiative.
        JAMA. 2007; 298: 1323-1325
        • Lundkvist J.
        • Ekman M.
        • Ericsson S.R.
        • Jonsson B.
        • Glimelius B.
        Proton therapy of cancer: potential clinical advantages and cost-effectiveness.
        Acta Oncol. 2005; 44: 850-861
        • Lundkvist J.
        • Ekman M.
        • Ericsson S.R.
        • Jonsson B.
        • Glimelius B.
        Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma.
        Cancer. 2005; 103: 793-801
        • Hirano E.
        • Fuji H.
        • Onoe T.
        • Kumar V.
        • Shirato H.
        • Kawabuchi K.
        Cost-effectiveness analysis of cochlear dose reduction by proton beam therapy for medulloblastoma in childhood.
        J Radiat Res. 2013;
        • Mailhot Vega R.
        • Kim J.
        • Hollander A.
        • Hattangadi-Gluth J.
        • Michalski J.
        • Tarbell N.J.
        • et al.
        Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.
        Cancer. 2015; 121: 1694-1702
        • Langendijk J.A.
        • Lambin P.
        • De Ruysscher D.
        • Widder J.
        • Bos M.
        • Verheij M.
        Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.
        Radiother Oncol. 2013; 107: 267-273
        • Lawrence T.S.
        • Feng M.
        Protons for prostate cancer: the dream versus the reality.
        J Natl Cancer Inst. 2013; 105: 7-8
        • Breneman J.C.
        • Donaldson S.S.
        • Constine L.
        • Merchant T.
        • Marcus K.
        • Paulino A.
        • et al.
        The Children’s Oncology Group Radiation Oncology Discipline: 15 Years of Contribution to the Treatment of Childhood Cancer.
        Int J Radiat Oncol Biol Phys. 2018;
        • Thomas P.R.
        • Deutsch M.
        • Kepner J.L.
        • Boyett J.M.
        • Krischer J.
        • Aronin P.
        • et al.
        Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.
        J Clin Oncol. 2000; 18: 3004-3011
        • Packer R.J.
        Childhood medulloblastoma: progress and future challenges.
        Brain Dev. 1999; 21: 75-81
        • Eaton B.R.
        • Esiashvili N.
        • Kim S.
        • Weyman E.A.
        • Thornton L.T.
        • Mazewski C.
        • et al.
        Clinical outcomes among children with standard-risk medulloblastoma treated with proton and photon radiation therapy: a comparison of disease control and overall survival.
        Int J Radiat Oncol Biol Phys. 2016; 94: 133-138
        • Jakacki R.I.
        • Burger P.C.
        • Zhou T.
        • Holmes E.J.
        • Kocak M.
        • Onar A.
        • et al.
        Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.
        J Clin Oncol. 2012; 30: 2648-2653
        • Sharma R.A.
        • Plummer R.
        • Stock J.K.
        • Greenhalgh T.A.
        • Ataman O.
        • Kelly S.
        • et al.
        Clinical development of new drug-radiotherapy combinations.
        Nat Rev Clin Oncol. 2016; 13: 627-642
        • Marciscano A.E.
        • Walker J.M.
        • McGee H.M.
        • Kim M.M.
        • Kunos C.A.
        • Monjazeb A.M.
        • et al.
        Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.
        J Immunother Cancer. 2018; 6: 6
        • Schlaff C.D.
        • Krauze A.
        • Belard A.
        • O'Connell J.J.
        • Camphausen K.A.
        Bringing the heavy: carbon ion therapy in the radiobiological and clinical context.
        Radiat Oncol. 2014; 9: 88
        • Girdhani S.
        • Sachs R.
        • Hlatky L.
        Biological effects of proton radiation: what we know and don't know.
        Radiat Res. 2013; 179: 257-272
        • Alan Mitteer R.
        • Wang Y.
        • Shah J.
        • Gordon S.
        • Fager M.
        • Butter P.P.
        • et al.
        Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species.
        Sci Rep. 2015; 5: 13961
        • Zhang X.
        • Lin S.H.
        • Fang B.
        • Gillin M.
        • Mohan R.
        • Chang J.Y.
        Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation.
        J Thorac Oncol. 2013; 8: 1484-1491
        • McNamara A.L.
        • Schuemann J.
        • Paganetti H.
        A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.
        Phys Med Biol. 2015; 60: 8399-8416
        • Mohan R.
        • Peeler C.R.
        • Guan F.
        • Bronk L.
        • Cao W.
        • Grosshans D.R.
        Radiobiological issues in proton therapy.
        Acta Oncol. 2017; 56: 1367-1373
        • Kasper H.B.
        • Raeke L.
        • Indelicato D.J.
        • Symecko H.
        • Hartsell W.
        • Mahajan A.
        • et al.
        The pediatric proton consortium registry: a multi-institutional collaboration in U.S. proton centers.
        Int J Particle Therapy. 2014; 1: 323-333
        • Armstrong G.T.
        • Liu W.
        • Leisenring W.
        • Yasui Y.
        • Hammond S.
        • Bhatia S.
        • et al.
        Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study.
        J Clin Oncol. 2011; 29: 3056-3064
        • Armstrong G.T.
        • Stovall M.
        • Robison L.L.
        Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study.
        Radiat Res. 2010; 174: 840-850
        • Brinkman T.M.
        • Merchant T.E.
        • Li Z.
        • Brennan R.
        • Wilson M.
        • Hoehn M.E.
        • et al.
        Cognitive function and social attainment in adult survivors of retinoblastoma: a report from the St.Jude Lifetime Cohort Study.
        Cancer. 2015; 121: 123-131
        • Gunther J.R.
        • Sato M.
        • Chintagumpala M.
        • Ketonen L.
        • Jones J.Y.
        • Allen P.K.
        • et al.
        Imaging changes in pediatric intracranial ependymoma patients treated with proton beam radiation therapy compared to intensity modulated radiation therapy.
        Int J Radiat Oncol Biol Phys. 2015; 93: 54-63
        • Yock T.I.
        • Bhat S.
        • Szymonifka J.
        • Yeap B.Y.
        • Delahaye J.
        • Donaldson S.S.
        • et al.
        Quality of life outcomes in proton and photon treated pediatric brain tumor survivors.
        Radiother Oncol. 2014; 113: 89-94
        • Viswanathan V.
        • Pradhan K.R.
        • Eugster E.A.
        Pituitary hormone dysfunction after proton beam radiation therapy in children with brain tumors.
        Endocr Pract. 2011; 17: 891-896
        • Song S.
        • Park H.J.
        • Yoon J.H.
        • Kim D.W.
        • Park J.
        • Shin D.
        • et al.
        Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors.
        Acta Oncol. 2014; 53: 1158-1164
        • Rieber J.G.
        • Kessel K.A.
        • Witt O.
        • Behnisch W.
        • Kulozik A.E.
        • Debus J.
        • et al.
        Treatment tolerance of particle therapy in pediatric patients.
        Acta Oncol. 2015; 54: 1049-1055
        • Sethi R.V.
        • Shih H.A.
        • Yeap B.Y.
        • Mouw K.W.
        • Petersen R.
        • Kim D.Y.
        • et al.
        Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.
        Cancer. 2014; 120: 126-133
        • Green D.M.
        • Merchant T.E.
        • Billups C.A.
        • Stokes D.C.
        • Broniscer A.
        • Bartels U.
        • et al.
        Pulmonary function after treatment for embryonal brain tumors on SJMB03 that included craniospinal irradiation.
        Int J Radiat Oncol Biol Phys. 2015; 93: 47-53
        • Bolling T.
        • Weege J.
        • Eich H.T.
        • Timmermann B.
        • Meyer F.M.
        • Rube C.
        • et al.
        Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. results of the “registry for the evaluation of side effects after radiotherapy in childhood and adolescence”.
        Head Neck. 2015; 37: 1137-1141
        • Macdonald S.M.
        • Sethi R.
        • Lavally B.
        • Yeap B.Y.
        • Marcus K.J.
        • Caruso P.
        • et al.
        Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.
        Neuro Oncol. 2013; 15: 1552-1559
        • Ares C.
        • Albertini F.
        • Frei-Welte M.
        • Bolsi A.
        • Grotzer M.A.
        • Goitein G.
        • et al.
        Pencil beam scanning proton therapy for pediatric intracranial ependymoma.
        J Neurooncol. 2016; 128: 137-145
        • Sato M.
        • Gunther J.R.
        • Mahajan A.
        • Jo E.
        • Paulino A.C.
        • Adesina A.M.
        • et al.
        Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.
        Cancer. 2017; 123: 2570-2578
        • McGovern S.L.
        • Okcu M.F.
        • Munsell M.F.
        • Kumbalasseriyil N.
        • Grosshans D.R.
        • McAleer M.F.
        • et al.
        Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.
        Int J Radiat Oncol Biol Phys. 2014; 90: 1143-1152
        • Iwata S.
        • Yonemoto T.
        • Ishii T.
        • Kumagai K.
        • Imai R.
        • Hagiwara Y.
        • et al.
        Efficacy of carbon-ion radiotherapy and high-dose chemotherapy for patients with unresectable Ewing's sarcoma family of tumors.
        Int J Clin Oncol. 2013; 18: 1114-1118